Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the fourth quarter and full year ended December ...

Revenue excluding its GLP-1 offering increased 43% to $1.2 billion in 2024 from a year earlier, said Chief Financial Officer Yemi Okupe. Including sales of its weight-loss treatments, revenue surged ...

On Friday, the Food and Drug Administration declared the semaglutide shortage over, sending Hims & Hers shares down 26%.

Compounding pharmacy and IBD 50 newcomer Hims & Hers Health reported bullish earnings and sales growth late Monday. But Hims ...

Ciara Miller detailed exactly what she has in mind for her health and fitness for 2025. Get the details of our exclusive ...

Stocks in Focus. In this article, we are going to take a look at where Hims & Hers Health, Inc. (NYSE:HIMS) stands against ...

Hims & Hers plans to launch a generic version of liraglutide, but its efficacy is significantly lower than semaglutide. See ...

Sue Dumbauld's job was straining her heart. After losing weight, improving her cholesterol, she was in great shape for ...

A 9-year-old girl from Buffalo, N.Y., has died from complications from the flu, which landed her in the hospital in critical ...

In her debut book, award-winning reporter Alia Dastagir reckons with the harm, harassment and abuse women face on the internet.

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the ...

The soap legend has opened up about her health struggles, admitting she goes off balance, even walking down the stairs ...